Leerink cuts target for Henry Schein stock to USD 92.00

Published on 10/15/2026 at 18:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 6.70 percent to USD 3.46 billion. Henry Schein stock costs EUR 77.25 on October 15, 2026 at 6:18 p.m. CEST.

Analyst view and operating scale

On October 14, 2026, Leerink lowered its Henry Schein target to USD 92.00 from USD 96.00.
Revenue rose 6.70 percent to USD 3.46 billion in the second quarter of 2026.
Henry Schein stock costs EUR 77.25 at Lang & Schwarz on October 15, 2026 at 6:18 p.m. CEST.
Henry Schein reported a P/E ratio of 25.31 and a market capitalization of USD 9.7 billion.

Moderne Zahnarztpraxis mit Behandlungsstuhl und medizinischen Instrumenten, Henry Schein Sektor — Henry Schein US42548G1040 versorgt Zahnarztpraxen weltweit mit hochwertigen medizinischen Produkten und Dentalgeräten, Illustration mit AI erstellt.

Leerink cut its Henry Schein price target to USD 92.00 from USD 96.00 on October 14, 2026, while keeping a Market Perform rating, according to Markets Insider. That target is 6.04 percent above Henry Schein's USD 86.76 Nasdaq price on October 15, 2026 at 12:29 p.m. EDT. Henry Schein stock was trading at EUR 77.25 at Lang & Schwarz on October 15, 2026 at 6:18 p.m. CEST.

Second-quarter sales provide scale

Henry Schein generated USD 3.46 billion in revenue in the second quarter of 2026, an increase of 6.70 percent from the year-earlier quarter. The company reported non-GAAP earnings per share of USD 1.27, up 15.50 percent year over year, according to the Yahoo Finance transcript dated August 4, 2026.

Price position and valuation

The Nasdaq listing had a 52-week range of USD 61.95 to USD 92.18 as of October 14, 2026. Its market capitalization was USD 9.7 billion, and the trailing P/E ratio was 25.31 on the same date. Henry Schein's year-to-date performance was 13.20 percent, according to the quoted market figures.

What comes next for earnings?

Yahoo Finance lists November 3, 2026 as Henry Schein's next earnings date. The upcoming report will give investors a fresh test of the company's sales growth and its raised full-year outlook for 4.50 percent to 5.50 percent sales growth.

Comparison with peers

Henry Schein (Nasdaq, USD): P/E 25.31, market capitalization USD 9.7 billion.
Cardinal Health (NYSE, USD): plus 1.73 percent, P/E 34.81, market capitalization USD 58.4 billion.
McKesson (NYSE, USD): plus 2.01 percent, P/E 26.68, market capitalization USD 116.2 billion.

Henry Schein stock at Lang & Schwarz

Henry Schein stock was trading at EUR 77.25 at Lang & Schwarz on October 15, 2026 at 6:18 p.m. CEST. The Nasdaq price was USD 86.76 at 12:29 p.m. EDT on the same date.

The further course of trading is shown by the continuously updated real-time quote of Henry Schein stock.